Alaunos Therapeutics, Inc. (TCRT)
CIK 1107421 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Alaunos Therapeutics, Inc..
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| Aug 14, 2026 | 10-Q | 0001193125-26-352421 |
| Aug 11, 2026 | 4 | 0001193125-26-344682 |
| Jul 27, 2026 | 4 | 0001193125-26-318114 |
| Jul 27, 2026 | 4 | 0001193125-26-318103 |
| Jul 27, 2026 | 4 | 0001193125-26-318100 |
| Jul 27, 2026 | 4 | 0001193125-26-318105 |
| Jul 6, 2026 | S-8 | 0001193125-26-295169 |
| Jul 2, 2026 | 4 | 0001193125-26-295004 |
| Jun 29, 2026 | 8-K | 0001193125-26-286914 |
| Jun 17, 2026 | 4 | 0001193125-26-274305 |
| May 27, 2026 | 4 | 0001193125-26-241999 |
| May 26, 2026 | 8-K | 0001193125-26-238237 |
| May 18, 2026 | 8-K | 0001193125-26-227921 |
| May 15, 2026 | 10-Q | 0001193125-26-227272 |
| May 1, 2026 | 4 | 0001193125-26-201489 |
| May 1, 2026 | 4 | 0001193125-26-201557 |
| May 1, 2026 | 4 | 0001193125-26-201474 |
| Apr 30, 2026 | 10-K/A | 0001193125-26-197838 |
| Apr 15, 2026 | 8-K | 0001193125-26-157126 |
| Mar 31, 2026 | 10-K | 0001193125-26-134720 |
| Mar 5, 2026 | SCHEDULE 13D/A | 0002094682-26-000002 |
| Mar 2, 2026 | 8-K | 0001193125-26-084084 |
| Feb 24, 2026 | SCHEDULE 13D/A | 0002094682-26-000001 |
| Jan 15, 2026 | 4 | 0001193125-26-014117 |
| Jan 15, 2026 | 4 | 0001193125-26-014116 |